Archive for December 2022
Survey finds CT hospital collections policies allow lawsuits and denial of care
A recent survey by Kaiser Health News found that many US hospitals have aggressive policies for patients who can’t pay their bills. Policies include lawsuits, reporting to credit rating agencies, selling the debt to collectors, and even denying non-emergency care. Medical debt affects one in five US households and the average debt is $21,687. The…
Read MoreUpdate: Policy options to support competition and control healthcare prices
Download the fact sheet Download the updated resource list Healthcare service prices are the main driver of Connecticut’s rising health insurance premiums. The consolidation of hospitals and providers into large health systems has stifled competition, allowing prices to rise unchecked. Other states have taken action to protect competition in consolidated markets and it’s working. Connecticut…
Read MoreBook Club — The Data Detective
The Data Detective: Ten Easy Rules to Make Sense of Statistics follows on the Book Club’s obsession with statistics and good data analysis (here, here, here, and here). Good policy rests on good evidence. There are good sources, including the books linked above, that uncover misleading information, with clues to identify them, and that’s important.…
Read MoreCTNJ Analysis: Good News on Healthcare Costs, But It Won’t Last
Tuesday’s eagerly anticipated inflation report from the Bureau of Labor Statistics had good news for our battered economy – inflation is down for the fifth month in a row. But the counter-intuitive part is that prices for medical care helped lower inflation. I rarely get to report good news on healthcare costs. Of course, there…
Read MoreCTNJ op-ed: Health insurance affordability review is good, but it’s no silver bullet
A movement to include affordability in the Insurance Department’s review of health insurance premiums is gaining champions. That’s a good thing. The best care is useless if you can’t afford it. Holding insurers accountable for lowering costs is important, but it’s not going to solve everything. We need to do much more to get costs…
Read MoreNo evidence to justify increases for 7 of top 10 most costly drugs
The latest Unsupported Price Increase report from the Institute for Clinical and Economic Review finds that, last year, seven of the ten most costly drugs in the US that raised net prices well over the rate of general inflation, had no new clinical evidence of effectiveness to justify the increases. The increases on just these…
Read More